Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Biofrontera (BFRI) Shares Outstanding (2020 - 2025)

Biofrontera (BFRI) has 6 years of Shares Outstanding data on record, last reported at $11.6 million in Q3 2025.

  • For Q3 2025, Shares Outstanding rose 78.39% year-over-year to $11.6 million; the TTM value through Sep 2025 reached $11.6 million, up 78.39%, while the annual FY2024 figure was $10129.0, 99.33% down from the prior year.
  • Shares Outstanding reached $19881.0 in Q3 2025 per BFRI's latest filing, up from $3019.0 in the prior quarter.
  • Across five years, Shares Outstanding topped out at $19.0 million in Q2 2022 and bottomed at $3019.0 in Q2 2025.
  • Average Shares Outstanding over 5 years is $3.9 million, with a median of $1.3 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding: skyrocketed 799900.0% in 2021, then plummeted 99.33% in 2024.
  • A 5-year view of Shares Outstanding shows it stood at $855237.0 in 2021, then skyrocketed by 56.09% to $1.3 million in 2022, then rose by 13.68% to $1.5 million in 2023, then tumbled by 99.33% to $10129.0 in 2024, then surged by 114899.73% to $11.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $11.6 million in Q3 2025, $10.1 million in Q2 2025, and $8.9 million in Q1 2025.